Serum ferritin and death from all causes and cardiovascular disease: The NHANES II mortality study

Annals of Epidemiology

Volumn 10, Issue 7, 2000, Pages 441-448

  Sempos, Christopher T ^a   Looker, Anne C ^b   Gillum, Richard F ^b   McGee, Daniel L ^c   Vuong, Cuong V ^b   Johnson, Clifford L ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cardiovascular disease; Coronary heart disease; Death; Ferritin; Iron

Indexed keywords

FERRITIN; IRON;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEART INFARCTION; HUMAN; HYPOTHESIS; ISCHEMIC HEART DISEASE; MALE; MODEL; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RACE; SEX DIFFERENCE;

AFRICAN AMERICANS; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0033823617     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(00)00068-5     Document Type: Article

References (65)

1. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet. 1:1981;1293-1294.
2. Sullivan J.L. Iron versus cholesterol - perspectives on the iron heart disease debate. J Clin Epidemiol. 49:1996;1345-1352.
3. Salonen J.T., Nyyssönen K., Korpela H., Toumilehto J., Seppänen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 86:1992;803-811.
4. Reaven P.D., Witztum J.L. Oxidized low density lipoproteins in atherogenesis. Role of dietary modification Ann Rev Nutr. 16:1996;150-171.
5. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis. Implications for the oxidized low density protein hypothesis Atherosclerosis. 141:1998;1-15.
6. Yuan X.M., Brunk U.T. Iron and LDL-oxidation in atherogenesis. APMIS. 106:1998;825-842.
7. Sempos C.T., Looker A.C., Gillum R.F. Iron and heart disease. The epidemiologic data Nutr Rev. 54:1996;73-84.
8. Corti M.C., Gaziano M., Hennekens C.H. Iron status and risk of cardiovascular disease. Ann Epidemiol. 7:1997;62-68.
9. Thorgeirsson G., Magnusson M.K. Iron metabolism and coronary heart disease. Primary Cardiology. 21:1995;17-20.
10. Danesh J., Appleby P. Coronary heart disease and iron status. Meta-analysis of prospective studies. Circulation. 99:1999;852-854.
11. Meyers D.G. The iron hypothesis - Does Iron cause atherosclerosis? Clin Cardiol. 19:1996;925-929.
12. Toumainen T.P., Punnonen K., Nyyssönen K., Salonen J.T. Association between body iron stores and risk of acute myocardial infarction in men. Circulation. 97:1998;1461-1466.
13. Salonen J.T., Tuomainen T.-P., Salonen R., Lakka T.A., Nyyssönen K. Donation of blood is associated with reduced risk of myocardial infarction. Am J Epidemiol. 148:1998;445-451.
14. McDowell A., Engle A., Massey J.T., Maurer K. Plan and Operation of the Second National Health and Nutrition Examination Survey, 1976-80. National Center for Health Statistics. Vital Health Stat. 1(15):1981.
15. Loria C.M., Sempos C.T., Vuong C.V. Plan and Operations of the NHANES II Mortality Study, 1992. Vital Health Stat. 1(38):1999.
16. Stampfer M.J., Willett W.C., Speizer F.E., Dysert D.C., Lipnick R., Rosner B., Hennekens C.H. Test of the National Death Index. Am J Epidemiol. 119:1984;837-839.
17. Williams B.C., Demitrack L.B., Fries B.E. The accuracy of the National Death Index when personal identifier other than Social Security number are used. Am J Pub Health. 82:1992;1145-1147.
18. Israel R.A., Rosenberg H.M., Curtin L.R. Analytic potential for multiple cause-of-death data. Am J Epidemiol. 124:1986;161-179.
19. Miles L.E.M., Lipschitz D.A., Bieber C.P., Cook J.D. Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem. 61:1974;209-224.
20. Looker A.C., Gunter E.W., Cook J.D., Green R., Harris J.W. Comparing serum ferritin values from different population surveys. National Center for Health Statistics. Vital Health Stat. 2(111):1991.
21. Fulwood R., Johnson C.L., Bryner J.T., Gunter E.W., McGrath M.T. Hematological and Nutritional Biochemistry Reference Data for Persons 6 Months-74 Years of Age. United States, 1976-80 Vital Health Stat. 11(232):1982.
22. Lipid Research Clinics Program. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Bethesda, MD: National Institutes of Health. 1974:1. Revised 1982. DHEW Publication NIH 75-628.
23. Burt V., Cutler J.A., Higgins M., Horan M.J., Labarthe D., Whelton P., Brown C., Roccella E.J. Trends in prevalence, awareness, treatment, and control of hypertension in the adult US population. Hypertension. 26:1995;60-69.
24. Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr. 42:1985;1318-1330.
25. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press. 1989.
26. Shah BV, Barnwell BG, Bieler GS. SUDAAN Users's Manual Release 7.0. Research Triangle Park, NC: Research Triangle Institute. 1996.
27. Ingram DD, Makuc DM. Statistical issues in analyzing the NHANES I Epidemiologic Follow-up Study. Vital Health Stat 2(121). 1994.
28. Harrell F.E., Lee K.L., Mark D.B. Tutorial in biostatistics. Multivariable prognostic models. Issues in developing models, evaluating assumptions and adequacy and measuring and reducing errors Stat Med. 15:1996;361-387.
29. Magnusson M.K., Sigfusson N., Sigvaldason H., Johannesson G.M., Magnusson S., Thorgeirsson G. Low iron-binding capacity as a risk factor for myocardial infarction. Circulation. 89:1994;102-108.
30. Stampfer M.J., Grodstein F., Rosenberg I., Willett W., Hennekens C. A prospective study of plasma ferritin and risk of myocardial infarction in US physicians. Circulation. 87:1993;688. [Abstract].
31. Mänttäri M., Manninen V., Huttunen J.K., Palosuo T., Ehnholm C., Heinonen O.P.et al. Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J. 15:1994;1599-1603.
32. Frey G.H., Krider D.W. Serum ferritin and myocardial infarct. West Virginia Medical J. 90:1994;13-15.
33. Kiechl S., Willeit J., Egger G., Poewe W., Oberholenzer F. Body iron stores and the risk of carotid atherosclerosis. Circulation. 96:1997;3300-3307.
34. Aronow W.S., Ahn C. Three-year follow-up shows no association of serum ferritin levels with incidence of new coronary events in 577 persons aged ≥62 years. Am J Cardiol. 78:1996;678-679.
35. Salonen J.T., Nyyssönen K., Salonen R. Body iron stores and the risk of coronary heart disease. N Engl J Med. 331:1994;1159. [Letter].
36. Toumainen TP, Punnonen K, Nyyssönen K, Salonen JT. Association between body iron stores and the risk of acute myocardial infarction. Circulation. 1998;1461-1466.
37. Aronow W.S. Serum ferritin is not a risk factor for coronary artery disease in men and women aged ≥62 years. Am J Cardiol. 72:1993;347-348.
38. Solymoss B.C., Marcil M., Gilfix B.M., Gelinas F., Poitras A.M., Campeau L. The place of ferritin among risk factors associated with coronary artery disease. Coronary Artery Disease. 5:1994;231-235.
39. Rauramaa R., Väisänen S., Mercuri M., Rankinen T., Penttila I., Bond M.G. Association of risk factors and body iron status to carotid atherosclerosis in middle-aged Eastern Finnish men. Eur Heart J. 15:1994;1020-1027.
40. Kiechl S., Aichner F., Gerstenbrand F., Egger G., Mair A., Rungger G.et al. Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck Study. Arterioscler Thromb. 14:1994;1625-1630.
41. Duthie G.G., Beattie J.A.G., Arthur J.R., Franklin M., Morrice P.C., James W.P.T. Blood antioxidants and indices of lipid peroixidation in subjects with stable angina. Nutrition. 10:1994;313-316.
42. Rengström J., Tonrvall P., Kallner A., Nilsson J., Hamsten A. Stored iron levels and myocardial infarction at a young age. Atherosclerosis. 106:1994;123-125.
43. Moore M., Folsom A.R., Barnes R.W., Eckfeldt J.H. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 141:1995;719-723.
44. van der Schouw Y.T., Verbeek A., Ruijs J. ROC curves for the initial assessment of new diagnostic tests. Family Practice. 9:1992;506-511.
45. Eichner J.E., Qi H., Moorre W.E., Schechter E. Iron measures in coronary angiography patients. Atherosclerosis. 136:1998;241-245.
46. Sempos C.T., Looker A.C., Gillum R.F., Makuc D.M. Body iron stores and the risk of coronary heart disease. N Engl J Med. 330:1994;1119-1124.
47. Liao Y., Cooper R.S., McGee D.L. Iron status and coronary heart disease. Negative findings from the NHANES I Epidemiologic Follow-up Study Am J Epidemiol. 139:1994;704-712.
48. Baer D.M., Tekawa I.S., Hurley L.B. Iron stores are not associated with acute myocardial infarction. Circulation. 89:1994;2915-2918.
49. Reunanen A., Takkunen H., Knekt P., Sappänen R., Aromaa A. Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med. 238:1995;223-230.
50. Asperen I.A., van Feskens E.J.M., Bowels C.H., Kromhout D. Body iron stores and mortality due to cancer and ischemic heart disease. A 17-year follow-up study of elderly men and women Int J Epidemiol. 24:1995;665-670.
51. Morrison H.I., Semenciw R.M., Mao Y., Wigle D.T. Serum iron and fatal acute myocardial infarction. Epidemiology. 5:1994;243-246.
52. Corti M.C., Guralnik J.M., Salvie M.E., Ferrucci L., Pahor M., Wallace R.B., Hennekens C.H. Serum iron level, coronary artery disease, and all cause mortality in older men and women. Am J Cardiol. 79:1997;120-127.
53. Endbergs A., Dorzewski A., Luft M., Mönnig G., Kleemann A., Schulte H., Assmann G., Breithhardt G., Kerber S. Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary atherosclerosis. Coronary Art Dis. 9:1998;119-124.
54. Salonen J.T., Korpela H., Nyyssönen K., Porkkala E., Toumainen T.P., Belcher J.D., Jacobs D.R., Salonen R. Lowering of body iron stores by blood letting and oxidation resistence of serum lipoproteins. A randomized cross-over trial in male smokers J Intern Med. 237:1995;161-168.
55. Weintraub W.S., Wenger N.K., Parthasaranthy S., Brown W.V. Hyperlipidemia versus iron overload and coronary heart disease. Yet more arguments on the cholesterol debate J Clin Epidemiol. 49:1996;1353-1358.
56. Halevy D., Thiery J., Nagel D., Arnold S., Erdmann E., Höfling B., Cremer P., Seidel D. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamnins E and C. Arterioscler Thromb Vasc Biol. 17:1997;1432-1437.
57. Iribarren C., Sempos C.T., Eckfeldt J.H., Folsom A. Lack of association between ferritin level and measures of LDL oxidation. The ARIC Study. Atherosclerosis. 139:1998;189-195.
58. Craig W.Y., Poulin Se Palomaki G.E., Neveux L.M., Ritchie R.F., Ledue T.B. Oxidation-related analytes and lipid and lipoprotein concentrations in adults. Arterioscler Thromb Vasc Biol. 15:1995;733-739.
59. Zock P.L., Katan M.B. Diet, LDL oxidation, and coronary artery disease. Am J Clin Nutr. 68:1998;759-760. [Editorial].
60. Maggi E., Chiesa R., Melissano G., Castellano R., Astore D., Grossi A., Finardi G., Bellomo G. LDL oxidation in patients with severe carotid athersclerosis. A study of in vitro and in vivo oxidation markers. Arterioscler Thromb. 14:1994;1892-1899.
61. Iribarren C., Folsom A.R., Jacobs D.R., Gross M.D., Belcher J.D., Eckfeldt J.H. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;1171-1177.
62. Custer E.M., Finch C.A., Sobel R.E., Zettner A. Populations norms for serum ferritin. J Lab Clin Med. 126:1995;88-94.
63. Gabay C., Kushner I. Acute-phase proteins and other systematic responses to inflammation. N Engl J Med. 340:1999;448-454.
64. Danesh J., Collins R., Appleby P., Peto R. Fibrinogen, C-reactive protein, albumin or white cell count. Meta-analysis of prospective studies of coronary heart disease JAMA. 279:1998;1477-1482.
65. Gillum R.F., Mussolino M.E., Makuc D.M. Erythrocyte sedimentation rate and coronary heart disease. The NHANES I Epidemiologic Follow-up Study J Clin Epidemiol. 48:1995;353-361.